<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Laser-Assisted In Situ Keratomileusis Lasers-Patient Labeling Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Laser-Assisted In Situ Keratomileusis Lasers-Patient Labeling Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period</h1>
    <p class="timestamp">Published: 2022-10-11 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of July 28, 2022. In the notice of availability, FDA requested comments on draft guidance for industry and FDA staff entitled "Laser-Assisted In Situ Keratomileusis (LASIK) Lasers--Patient Labeling Recommendations." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit co...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-21971</p>
    <p><strong>Publication Date:</strong> 2022-10-11</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/10/11/2022-21971/laser-assisted-in-situ-keratomileusis-lasers-patient-labeling-recommendations-draft-guidance-for">https://www.federalregister.gov/documents/2022/10/11/2022-21971/laser-assisted-in-situ-keratomileusis-lasers-patient-labeling-recommendations-draft-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-21971</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
